Jing Wen

7PUBLICATIONS
28CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 19, 2026
Universal diseased-site targeting via glycolysis-driven lactic acid gradient.

|Apr 11, 2025
Combination Treatment of Rituximab and Therapeutic Vaccines Affords Superior Tumor Suppression and Relapse Prevention for Non-Hodgkin Lymphoma.

Tong Qi, Jimin Guo, Zheng Cao

|Nov 05, 2024
A Multi-Enzyme Nanocascade to Target Disease-Relevant Metabolites.

Zheng Cao, Jie Ren, Alena Yang

|Oct 11, 2023
Lactate oxidase nanocapsules boost T cell immunity and efficacy of cancer immunotherapy.

Zheng Cao, Duo Xu, Jeffrey Harding

|Jul 20, 2021
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques.

Jing Wen, Tracy Cheever, Lan Wang

|Aug 09, 2020
The clonal repopulation of HSPC gene modified with anti-HIV-1 RNAi is not affected by preexisting HIV-1 infection.

Gajendra W Suryawanshi, Wannisa Khamaikawin, Jing Wen

Pageof 2

Frequent Collaborators

4 joint publications

Irvin S Y Chen

3 joint publications

Yunfeng Lu

2 joint publications

Chaoyong Liu

2 joint publications

Zheng Cao